These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31756900)

  • 1. Targeting Tumor Endothelial Cells with Nanoparticles.
    Sakurai Y; Akita H; Harashima H
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of tumor endothelial cells and drug delivery.
    Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels.
    Asai T
    Biol Pharm Bull; 2012; 35(11):1855-61. PubMed ID: 23123455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Tumor Endothelial Cells in Cancer Progression.
    Hida K; Maishi N; Annan DA; Hida Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
    Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
    J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
    Rajabi M; Adeyeye M; Mousa SA
    Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer.
    Pathak A; Jain NK; Jain K
    Expert Opin Drug Deliv; 2024 Aug; 21(8):1235-1250. PubMed ID: 39161976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis regulation by nanocarriers bearing RNA interference.
    Ofek P; Tiram G; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2017 Sep; 119():3-19. PubMed ID: 28163106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.
    de la Torre P; Pérez-Lorenzo MJ; Alcázar-Garrido Á; Flores AI
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems.
    Ying M; Chen G; Lu W
    Curr Pharm Des; 2015; 21(22):3066-75. PubMed ID: 26027578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape effect of carbon nanovectors on angiogenesis.
    Chaudhuri P; Harfouche R; Soni S; Hentschel DM; Sengupta S
    ACS Nano; 2010 Jan; 4(1):574-82. PubMed ID: 20043662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights and novel approaches for targeting tumor metastasis.
    Das SS; Alkahtani S; Bharadwaj P; Ansari MT; ALKahtani MDF; Pang Z; Hasnain MS; Nayak AK; Aminabhavi TM
    Int J Pharm; 2020 Jul; 585():119556. PubMed ID: 32574684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional polyurethane-urea nanoparticles to target and arrest inflamed vascular environment: a potential tool for cancer therapy and diagnosis.
    Morral-Ruíz G; Melgar-Lesmes P; Solans C; García-Celma MJ
    J Control Release; 2013 Oct; 171(2):163-71. PubMed ID: 23831054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers.
    Ryan GM; Kaminskas LM; Porter CJ
    J Control Release; 2014 Nov; 193():241-56. PubMed ID: 24801249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems.
    Narmani A; Rezvani M; Farhood B; Darkhor P; Mohammadnejad J; Amini B; Refahi S; Abdi Goushbolagh N
    Drug Dev Res; 2019 Jun; 80(4):404-424. PubMed ID: 31140629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional peptides for tumor therapy.
    Li K; Liu CJ; Zhang XZ
    Adv Drug Deliv Rev; 2020; 160():36-51. PubMed ID: 33080257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles' interactions with vasculature in diseases.
    Tee JK; Yip LX; Tan ES; Santitewagun S; Prasath A; Ke PC; Ho HK; Leong DT
    Chem Soc Rev; 2019 Oct; 48(21):5381-5407. PubMed ID: 31495856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.